© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 14, 1126-1135,
July 19, 2000
© 2000 Oxford University Press
REVIEW |
Genetic and Hormonal Risk Factors in Breast Cancer
Affiliation of authors: Department of Medicine, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia.
Correspondence to: Barbara L. Weber, M.D., Department of Medicine, Division of Hematology and Oncology, University of Pennsylvania, Rm. 316A, BRBII/III, 421, Curie Blvd., Philadelphia, PA 19104 (e-mail: weberb{at}mail.med.upenn.edu)
Breast cancer poses a serious public health problem, and it is hoped that identification of genetic and environmental factors that contribute to the development of breast cancer will enhance prevention efforts. Two breast cancer susceptibility genes (BRCA1 and BRCA2) have been identified, and germline mutations in these genes are thought to account for between 5% and 10% of all breast cancer cases. Current findings suggest that mutations in other highly penetrant genes may play an important role in breast cancer susceptibility, and studies aimed at the isolation of these genes are under way. In addition, common variants in a number of gene classes are thought to act as low-penetrance susceptibility alleles, and efforts to identify and characterize these variants are under way. This review discusses the genetic components of susceptibility to breast cancer from the standpoint of both human genetics and rat models.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Lee, D. Medina, A. Tsimelzon, S. K. Mohsin, S. Mao, Y. Wu, and D. C. Allred Alterations of Gene Expression in the Development of Early Hyperplastic Precursors of Breast Cancer Am. J. Pathol., July 1, 2007; 171(1): 252 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Y. Ting, B. F. Kimler, C. J. Fabian, and B. K. Petroff Characterization of a preclinical model of simultaneous breast and ovarian cancer progression Carcinogenesis, January 1, 2007; 28(1): 130 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ogura, M. Azuma, Y. Tsuboi, Y. Kabe, Y. Yamaguchi, T. Wada, H. Watanabe, and H. Handa TFII-I down-regulates a subset of estrogen-responsive genes through its interaction with an initiator element and estrogen receptor {alpha} Genes Cells, April 1, 2006; 11(4): 373 - 381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Gorin, A. R. Ashford, R. Lantigua, A. Hossain, M. Desai, A. Troxel, and D. Gemson Effectiveness of Academic Detailing on Breast Cancer Screening among Primary Care Physicians in an Underserved Community J Am Board Fam Med, March 1, 2006; 19(2): 110 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-N. P. Lee and V. L. W. Go Nutrient-Gene Interaction: Tracer-Based Metabolomics J. Nutr., December 1, 2005; 135(12): 3027S - 3032S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kumar, A. E. Gururaj, R. K. Vadlamudi, and S. K. Rayala The Clinical Relevance of Steroid Hormone Receptor Corepressors Clin. Cancer Res., April 15, 2005; 11(8): 2822 - 2831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Glaser, J. L. Hsu, and M. L. Gulley Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Rebbeck, T. Friebel, H. T. Lynch, S. L. Neuhausen, L. van 't Veer, J. E. Garber, G. R. Evans, S. A. Narod, C. Isaacs, E. Matloff, et al. Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group J. Clin. Oncol., March 15, 2004; 22(6): 1055 - 1062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Mincey Genetics and the Management of Women at High Risk for Breast Cancer Oncologist, October 1, 2003; 8(5): 466 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shin and I. M. Verma BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription PNAS, June 10, 2003; 100(12): 7201 - 7206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Powell, D. Piersma, M. E. Kevenaar, I. L. van Staveren, A. P. N. Themmen, B. J. Iacopetta, and E. M. J. J. Berns Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1653 - 1657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dalpe, L. Bouchard, A.-J. Houle, and L. Bedard Watching the Race to Find the Breast Cancer Genes Science Technology Human Values, April 1, 2003; 28(2): 187 - 216. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Domchek, A. Eisen, K. Calzone, J. Stopfer, A. Blackwood, and B. L. Weber Application of Breast Cancer Risk Prediction Models in Clinical Practice J. Clin. Oncol., February 15, 2003; 21(4): 593 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tsavachidou and M. N. Liebman Modeling and Simulation of Pathways in Menopause J. Am. Med. Inform. Assoc., September 1, 2002; 9(5): 461 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Spurdle, J. L. Hopper, X. Chen, G. S. Dite, M. R. E. McCredie, G. G. Giles, D. J. Venter, M. C. Southey, D. M. Purdie, and G. Chenevix-Trench The Steroid 5{alpha}-Reductase Type II TA Repeat Polymorphism Is Not Associated with Risk of Breast or Ovarian Cancer in Australian Women Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1287 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Ginger, M. F. Gonzalez-Rimbau, J. P. Gay, and J. M. Rosen Persistent Changes in Gene Expression Induced by Estrogen and Progesterone in the Rat Mammary Gland Mol. Endocrinol., November 1, 2001; 15(11): 1993 - 2009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis PNAS, October 12, 2001; (2001) 221459098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dork, R. Bendix, M. Bremer, D. Rades, K. Klopper, M. Nicke, B. Skawran, A. Hector, P. Yamini, D. Steinmann, et al. Spectrum of ATM Gene Mutations in a Hospital-based Series of Unselected Breast Cancer Patients Cancer Res., October 1, 2001; 61(20): 7608 - 7615. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 1, 2001; (2001) 171174298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Abdi, E. M. Bradbury, N. Doggett, and X. Chen Rapid characterization of DNA oligomers and genotyping of single nucleotide polymorphism using nucleotide-specific mass tags Nucleic Acids Res., July 1, 2001; 29(13): e61 - e61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Xu, S.-T. Kim, and M. B. Kastan Involvement of Brca1 in S-Phase and G2-Phase Checkpoints after Ionizing Irradiation Mol. Cell. Biol., May 15, 2001; 21(10): 3445 - 3450. [Abstract] [Full Text]
|
|
|
|
|
|
L. C. Verhoog, E. M. J. J. Berns, C. T. M. Brekelmans, C. Seynaeve, E. J. Meijers-Heijboer, and J. G. M. Klijn Prognostic Significance of Germline BRCA2 Mutations in Hereditary Breast Cancer Patients J. Clin. Oncol., November 1, 2000; 18(90001): 119s - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, L. A. Annab, C. A. Afshari, W.-H. Lee, and T. G. Boyer BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor PNAS, August 14, 2001; 98(17): 9587 - 9592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sivaraman, O. M. Conneely, D. Medina, and B. W. O'Malley p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis PNAS, October 23, 2001; 98(22): 12379 - 12384. [Abstract] [Full Text] [PDF]
|
|